Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knock-in mice

被引:20
|
作者
Kobayashi, M [1 ]
Ishiguro, K [1 ]
Katoh-Fukui, Y [1 ]
Yokoyama, M [1 ]
Fujita, SC [1 ]
机构
[1] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan
关键词
Alzheimer's disease; apolipoprotein E; hippocampus; knock-in mouse; phosphorylated tau; quantitative immunoblotting; tau kinase; tau; phosphatase;
D O I
10.1097/00001756-200304150-00008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The apolipoprotein E (apoE) epsilon4 allele is associated with an increased risk of sporadic as well as late-onset familial Alzheimer's disease (AD). To accurately determine the isoform-specific effects of human apoE on AD-like phosphorylation of tau, hippocampi from human apoE knock-in (KI) mice were studied by quantitative immunoblotting. There was no significant difference in phosphorylation levels of tau at nine of the 13 epitopes, for six of eight tau kinases, or in protein levels of three tau phosphatases, between apoE3-KI and apoE4-KI mouse hippocampi. However, in apoE4-KI mice, phosphorylation of tau at Ser235 was increased to similar to150%, that at Ser413 to similar to140%, while that at Ser202/Thr205 and Thr205 were decreased to similar to70%, and the protein level of tau protein kinase I/glycogen synthase kinase 3beta (TPKI/GSK3beta) was increased to similar to120%, that of extracellular signal-regulated kinase 2 (ERK2) was increased to similar to130%, compared with apoE3-KI mice.
引用
收藏
页码:699 / 702
页数:4
相关论文
共 50 条
  • [1] Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice
    Hamanaka, H
    Katoh-Fukui, Y
    Suzuki, K
    Kobayashi, M
    Suzuki, R
    Motegi, Y
    Nakahara, Y
    Takeshita, A
    Kawai, M
    Ishiguro, K
    Yokoyama, M
    Fujita, SC
    HUMAN MOLECULAR GENETICS, 2000, 9 (03) : 353 - 361
  • [2] Increased vulnerability to focal ischemic brain injury in human apolipoprotein E4 knock-in mice
    Mori, T
    Kobayashi, M
    Town, T
    Fujita, SC
    Asano, T
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (03): : 280 - 291
  • [3] Membrane cholesterol domains in mice expressing human apolipoprotein E3 and E4
    Wood, WG
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 : 110 - 110
  • [4] Conformational analysis of apolipoprotein E3/E4 heteromerization
    Tu, Kai-Han
    Abhari, Devan
    Narayanaswami, Vasanthy
    FEBS JOURNAL, 2019, 286 (10) : 1986 - 1998
  • [5] A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease
    Xu, Pu-Ting
    Li, Yi-Ju
    Qin, Xue-Jun
    Kroner, Charles
    Green-Odlum, Anya
    Xu, Hong
    Wang, Tian-Yuan
    Schmechel, Donald E.
    Hulette, Christine M.
    Ervin, John
    Hauser, Mike
    Haines, Jonathan
    Pericak-Vance, Margaret A.
    Gilbert, John R.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2007, 36 (03) : 313 - 331
  • [6] Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice
    Hayashi, H
    Igbavboa, U
    Hamanaka, H
    Kobayashi, M
    Fujita, SC
    Wood, WG
    Yanagisawa, K
    NEUROREPORT, 2002, 13 (04) : 383 - 386
  • [7] Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice
    Levi, Ofir
    Michaelson, Daniel M.
    JOURNAL OF NEUROCHEMISTRY, 2007, 100 (01) : 202 - 210
  • [8] Differential regulation of APP secretion by apolipoprotein E3 and E4
    Wolozin, BL
    BasaricKeys, J
    Canter, R
    Li, Y
    Vanderputten, D
    Sunderland, T
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 322 - 326
  • [9] Structural and functional variations in human apolipoprotein E3 and E4
    Chou, CY
    Jen, WP
    Hsieh, YH
    Shiao, MS
    Chang, GG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (19) : 13333 - 13344
  • [10] Differential regulation of APP secretion by apolipoprotein E3 and E4
    Wolozin, B
    BasaricKeys, J
    Canter, R
    Li, YH
    Strickland, D
    Sunderland, T
    NEURODEGENERATIVE DISEASES: MOLECULAR AND CELLULAR MECHANISMS AND THERAPEUTIC ADVANCES, 1996, : 97 - 102